HR 933 · 107th Congress 2001–2003, ended

Affordable HIV/AIDS Medicines for Poor Countries Act

Latest action · Mar 14, 2001 Referred to the Subcommittee on Trade.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 7, 2001
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Affordable HIV/AIDS Medicines for Poor Countries Act - Directs the Secretary of the Treasury, the Administrator of the U.S. Agency for International Development, and the U.S. Trade Representative (USTR) to encourage developing countries (including sub-Saharan African countries) and pharmaceutical companies to make HIV/AIDS pharmaceuticals and medical technologies available to people who live in such countries without charge or at affordable prices.

Sets forth certain restrictions and limitations, including that: (1) appropriated funds made available to U.S. agencies may not be obligated to seek the revocation or revision of any intellectual property or competition law or policy of a developing country (including any sub- Saharan African country) that regulates HIV/AIDS pharmaceuticals or medical technologies if such law or policy promotes access to such drugs and technologies by the country's population; and (2) the USTR may not initiate a proceeding in the World Trade Organization (WTO) challenging any law or policy of a developing country (including a sub-Saharan African country) that promotes access by HIV/AIDS pharmaceuticals or medical technologies by the population of the country.

Requires the President to direct the U.S. representative to the WTO to urge the WTO and member countries to exempt developing countries (including sub-Saharan African countries) from the application of any provision of the Agreement on Trade-Related Aspects of Intellectual Property Rights or any other international agreement relating to intellectual property rights that would prohibit or restrict such countries from establishing or implementing any law or policy that promotes access to HIV/AIDS pharmaceuticals or medical technologies to their population.

Cosponsors 62

Members who signed on, in the order they did. Signatures ran from Mar 7, 2001 to Jul 11, 2001; 9 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-CABarbara LeeOriginalMar 7, 2001
D-MABarney FrankOriginalMar 7, 2001
I-VTBernard SandersOriginalMar 7, 2001
D-VIDonna M. ChristensenOriginalMar 7, 2001
D-ILJanice D. SchakowskyOriginalMar 7, 2001
D-MIJohn Conyers, Jr.OriginalMar 7, 2001
D-CANancy PelosiOriginalMar 7, 2001
D-TXSheila Jackson LeeOriginalMar 7, 2001
D-OHSherrod BrownOriginalMar 7, 2001
D-MDAlbert Russell WynnMar 13, 2001
D-MNBetty McCollumMar 13, 2001
D-ILBobby L. RushMar 13, 2001
D-NYCharles B. RangelMar 13, 2001
D-MIDale E. KildeeMar 13, 2001
D-OHDennis J. KucinichMar 13, 2001

Withdrew 2 Edolphus Towns D-NY Apr 3, 2001·William J. Jefferson D-LA Jun 27, 2001

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseWays and Means Committee
Referred Mar 7, 2001
Trade Subcommittee
Referred Mar 14, 2001
HouseForeign Affairs Committee
Referred Mar 7, 2001

Actions 3

Everything that happened, newest first.

  1. Mar 14, 2001Referred to the Subcommittee on Trade.
  2. Mar 7, 2001Introduced in House
  3. Mar 7, 2001Referred to the Committee on Ways and Means, and in addition to the Committee on International Relations, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 2

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H1851Eva M. Clayton D-NCMay 2, 2001
House · ExtensionsDebate and remarks E400, H997Janice D. Schakowsky D-IL, Maxine Waters D-CAMar 20, 2001

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To require certain actions with respect to the availability of HIV/AIDS pharmaceuticals and medical technologies in developing countries, including sub-Saharan African countries.
Short Titles as Introduced
Affordable HIV/AIDS Medicines for Poor Countries Act

Subjects

Assigned by the Library of Congress. Policy area: International Affairs.

Text 1

Each version as it was printed, newest first.

  1. Mar 7, 2001Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.